Indeed, GBM organotypic cultures treated with the V-ATPase inhibitor displayed decreased levels of NESTIN and CD133 besides showing lesser expression of ATP6V1G1 (Figure 7D). This evidence concerns the gene PROM1 and glioblastoma.